Glaucoma: all 1,844 studies
Page 18 of 19. Open to participants first (233), then studies with results posted, then the rest; newest registration first within each.
- Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot StudyCompletedNCT00452998Not applicable
- Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle GlaucomaCompletedNCT00451152Phase 2
- Multidrug Resistance After Trabeculectomy With Mitomycin CCompletedNCT00449631
- Ologen (OculusGen)-Glaucoma MMC Control Trial in IndiaStatus unknownNCT00449098Phase 4
- Ologen (OculusGen)-Glaucoma Case Control Trial in IndiaCompletedNCT00448929Phase 3
- Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin TherapyCompletedNCT00444665Phase 4
- 24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus TravoprostCompletedNCT00444184Phase 4
- Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or GlaucomaCompletedNCT00443924Phase 1
- External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle GlaucomaStatus unknownNCT00443664Early Phase 1
- Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost MonotherapyStatus unknownNCT00442312Phase 4
- Effects of Travoprost on Neovascular GlaucomaWithdrawnNCT00441181Not applicable
- Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.Status unknownNCT00440336Not applicable
- Visual Function Changes After Intraocular Pressure ReductionCompletedNCT00435058Not applicable
- Outcome of Small Pupil Phacotrabeculectomy in Persons With Glaucoma and CataractStatus unknownNCT00434707
- Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines?CompletedNCT00430287
- Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal ControlsCompletedNCT00430274
- Neurovascular Coupling in Eyes of Glaucoma PatientsCompletedNCT00430209
- Neurovascular Coupling in Eyes of Glaucoma PatientsCompletedNCT00429819
- Long-Term IOP Fluctuation and VF Progression After Triple ProcedureCompletedNCT00428740
- Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma ProgressionCompletedNCT00424996
- Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & CellsTerminatedNCT00410267
- OculusGen-Glaucoma Historical Control Study in TaiwanTerminatedNCT00406822Phase 3
- The Role of Steroids Following Selective Laser TrabeculoplastyCompletedNCT00406042Not applicable
- Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?CompletedNCT00405431Not applicable
- Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve DiseasesCompletedNCT00404729Phase 4
- Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma DropsCompletedNCT00402493Not applicable
- 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed CombinationsCompletedNCT00397241Phase 4
- Intravitreal Bevacizumab for Neovascular GlaucomaCompletedNCT00384631Not applicable
- SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory GlaucomaSuspendedNCT00382395Phase 3
- IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive TherapyCompletedNCT00382226Phase 4
- Prevalence of Ocular Surface Disease in Glaucoma PatientsCompletedNCT00382122
- The Effect of Education on Patient ComplianceStatus unknownNCT00376974Phase 4
- A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00372931Phase 2
- Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00372827Phase 4
- Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic GlaucomaCompletedNCT00371072Phase 2/3
- Determinants of Compliance With Glaucoma TherapyCompletedNCT00362622
- Study of PGA Suture in OphthalmologyCompletedNCT00351429Phase 4
- Laser Iridotomy Versus Phacoemulsification in Acute Angle ClosureCompletedNCT00350428Not applicable
- Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage GlaucomaStatus unknownNCT00349414Phase 1/2
- Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to LatanoprostCompletedNCT00348400Phase 4
- A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular HypertensionCompletedNCT00348062Phase 4
- Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular HypertensionCompletedNCT00348023Phase 4
- The Efficacy of Selective Laser TrabeculoplastyStatus unknownNCT00347893
- Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to LatanoprostCompletedNCT00347841Phase 4
- Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%CompletedNCT00347802Phase 4
- Effectiveness of a Procedure for Previously Failed Glaucoma SurgeryCompletedNCT00347789
- Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments.CompletedNCT00347191
- Results of Mass Switch From Latanoprost to TravoprostCompletedNCT00347126
- INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINETerminatedNCT00347035Phase 4
- Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular PressureTerminatedNCT00346931Not applicable
- Role of Polymorphisms in the IL-1 Gene ClusterCompletedNCT00346541
- Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin CCompletedNCT00346489Phase 4
- Endoscopic Goniotomy for Infantile GlaucomaCompletedNCT00338533Not applicable
- Adult Providing Access to the Visual Environment (PAVE) - Glaucoma PilotCompletedNCT00338208Not applicable
- Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in CanadaCompletedNCT00334750
- Compliance With Once Daily Glaucoma MedicationCompletedNCT00333463
- A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00333125Phase 3
- 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension PatientsCompletedNCT00330577Phase 4
- An Evaluation of Use of Topical Ocular Hypotensive Medication by ComplianceCompletedNCT00329095Phase 4
- Optic Nerve Compliance StudyCompletedNCT00328835Not applicable
- Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) GlaucomaCompletedNCT00327613
- mRNA Expression in Lymphocytes of Glaucoma PatientsCompletedNCT00327509
- Results of Ocular Compression and Suture Release in Trabeculectomy and Combined SurgeryCompletedNCT00327405
- Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's DiseaseWithdrawnNCT00327301
- A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00326092Phase 2
- A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2Status unknownNCT00326079Phase 4
- A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.CompletedNCT00326066Not applicable
- A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma SubjectsCompletedNCT00326040Phase 4
- A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.CompletedNCT00326014Phase 4
- Psychopathology of Normal-tension Glaucoma in Hong Kong Chinese Out-patientStatus unknownNCT00324181
- Analysis of Clinical Profiles of Chinese Patients With Normal Tension GlaucomaStatus unknownNCT00321386
- Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin HospitalCompletedNCT00321035Phase 3
- Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan HospitalCompletedNCT00320957Phase 3
- Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing HospitalCompletedNCT00320762Phase 3
- Anecortave Acetate in Patients With Open-angle GlaucomaCompletedNCT00320203Phase 2
- Study of Medical Treatment of Low-Pressure (Normal Tension) GlaucomaCompletedNCT00317577Phase 2
- A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00314171Phase 3
- A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00314158Phase 3
- Obstructive Sleep Apnea Syndrome in GlaucomaTerminatedNCT00313092
- Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?CompletedNCT00312403Not applicable
- A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00311389Phase 3
- Influence of Prostaglandins on Ocular Blood Flow in Glaucoma PatientsCompletedNCT00308945Phase 4
- Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid CompositionStatus unknownNCT00306657Not applicable
- Assessment of the Ability to Distinguish Odors in Glaucoma PatientsCompletedNCT00304824
- Compliance and Administration Technique in Topical Drug Therapy of GlaucomaCompletedNCT00303121
- Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular HypertensionCompletedNCT00300079Phase 4
- A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293800Phase 3
- A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293787Phase 3
- A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293761Phase 3
- Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00288951Phase 3
- A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00287521Phase 2
- Choroidal Blood Flow Response to Hand-grip Test in Progressive GlaucomaWithdrawnNCT00284440
- Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery DeviceWithdrawnNCT00283764Phase 3
- Autoimmune Dysregulation in Pigmentary GlaucomaCompletedNCT00280345Not applicable
- Ultrasonic Evaluation of Ocular TissuesStatus unknownNCT00279695
- A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaCompletedNCT00277498Phase 3
- Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy HumansWithdrawnNCT00275756Not applicable
- Assessing Cosopt Switch PatientsCompletedNCT00273442Phase 4
- Combined Phacotube vs Phacotrabeculectomy:A Randomized Controlled TrialStatus unknownNCT00273221Phase 4
- Clinical and Molecular Studies in Families With Glaucoma and Related DiseasesCompletedNCT00272363